Apogee Therapeutics Inc
APGE
ISIN US03770N1019 / Valor 127988711
Apogee Therapeutics Inc
UMushroom community rating:
About company
Apogee Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative biologic therapies for the treatment of atopic dermatitis, chronic obstructive pulmonary disease (COPD), asthma, and other inflammatory and immune diseases with significant unmet medical needs. The company's pipeline includes differentiated biologics designed to address these conditions, aiming to improve patient outcomes through advanced therapeutic solutions. By leveraging cutting-edge research and development, Apogee Therapeutics seeks to provide effective treatments for complex and chronic diseases that currently lack adequate medical options.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
2219 M
Market cap (USD)
97,786
Daily traded volume (Shares)
52.08 / 50.74
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
